Literature DB >> 27497912

Pulmonary involvement in systemic sclerosis.

Adriana Morales-Cárdenas1, Camila Pérez-Madrid1, Liliana Arias2, Paulina Ojeda3, María Paula Mahecha1, Adriana Rojas-Villarraga1, Jorge A Carrillo-Bayona2, Juan-Manuel Anaya4.   

Abstract

Systemic sclerosis (SSc) is a multi-systemic autoimmune disease that mainly affects the skin, lungs, gastrointestinal tract, heart and kidneys. Pulmonary disease in patients with SSc is strongly associated with mortality. The mechanisms involved into its pathophysiology include the activation of autoimmune cells and hyperplasia of fibroblasts with an increased capacity to produce collagen and diminished collagen breakdown. Although pulmonary biopsy is the gold standard for the diagnosis of interstitial lung disease in SSc, the most commonly used method is high-resolution computed tomography due to its high sensitivity and specificity. Herein, a comprehensive review on the pulmonary involvement in SSc is presented highlighting the radiologic-pathologic correlations.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Pathology; Pulmonary involvement; Radiology; Systemic sclerosis; Tomography; X-ray computed

Mesh:

Year:  2016        PMID: 27497912     DOI: 10.1016/j.autrev.2016.07.025

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  13 in total

1.  The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Authors:  Thi Dan Linh Nguyen-Kim; Britta Maurer; Yossra A Suliman; Fabian Morsbach; Oliver Distler; Thomas Frauenfelder
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

3.  Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.

Authors:  Chenxi Liu; Yong Hou; Dong Xu; Liubing Li; Yanfang Zhang; Linlin Cheng; Songxin Yan; Fengchun Zhang; Yongzhe Li
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

4.  RGC32 Promotes Bleomycin-Induced Systemic Sclerosis in a Murine Disease Model by Modulating Classically Activated Macrophage Function.

Authors:  Chenming Sun; Shi-You Chen
Journal:  J Immunol       Date:  2018-03-05       Impact factor: 5.422

Review 5.  Autoimmunity in 2016.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

6.  Effect size of rituximab on pulmonary function in the treatment of connective-tissue disease-related interstitial lung disease: a systematic review and meta-analysis.

Authors:  Yuanchen Zhao; Yang Gao; Tananchai Petnak; Wisit Cheungpasitporn; Charat Thongprayoon; Xing Zhang; Teng Moua
Journal:  Respir Res       Date:  2022-06-21

Review 7.  Focus on Nivolumab in NSCLC.

Authors:  Diego L Cortinovis; Stefania Canova; Marida Abbate; Francesca Colonese; Paolo Bidoli
Journal:  Front Med (Lausanne)       Date:  2016-12-13

8.  Effects of arterial blood on the venous blood vessel wall and differences in percentages of lymphocytes and neutrophils between arterial and venous blood.

Authors:  Li-Ping Peng; Juan Wen; Kan Yang; Shao-Li Zhao; Jia Dai; Zhong-Shu Liang; Yu Cao
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

9.  Development of PBC/SSc overlap syndrome in chronic GVHD patient: immunological implications in the presence of mitochondrial, nucleolar and spindle midzone autoantigens.

Authors:  Roberto Assandri; Federico Serana; Alessandro Montanelli
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

10.  Scleroderma-related interstitial lung disease.

Authors:  Sally Suliman; Abdalhamid Al Harash; William Neil Roberts; Rafael L Perez; Jesse Roman
Journal:  Respir Med Case Rep       Date:  2017-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.